drugset / Trial / NCT02676856
Hematopoietic Stem Cell Microtransplantation for in AML
Unknown
40 enrolled
Nanfang Hospital, Southern Medical University
Guangzhou First People's Hospital · collabPeking University People's Hospital · collabSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · collabThird Affiliated Hospital, Sun Yat-Sen University · collabZhujiang Hospital · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy of hematopoietic stem cell microtransplantation for in acute myeloid leukemia (AML)patients who can not receive hematopoietic stem cell transplantation (HSCT).
Timeline
- Start
- 2016-02
- Primary completion
- 2018-02
- Completion
- 2018-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Cladribine | Small molecule | 5 mg/m2 | — |
| Background | Cytarabine | Small molecule | 200 mg/m2 | — |
| Background | Cytarabine | Small molecule | 3000 mg/m2 | — |
| Background | IDA | Unknown | 12 mg/m2 | — |